These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 10767368)
21. Does a Positive Axillary Lymph Node Needle Biopsy Result Predict the Need for an Axillary Lymph Node Dissection in Clinically Node-Negative Breast Cancer Patients in the ACOSOG Z0011 Era? Pilewskie M; Mautner SK; Stempel M; Eaton A; Morrow M Ann Surg Oncol; 2016 Apr; 23(4):1123-8. PubMed ID: 26553439 [TBL] [Abstract][Full Text] [Related]
22. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients. Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881 [TBL] [Abstract][Full Text] [Related]
23. Quantitative detection of micrometastases in the lymph nodes of gastric cancer patients with real-time RT-PCR: a comparative study with immunohistochemistry. Kubota K; Nakanishi H; Hiki N; Shimizu N; Tsuji E; Yamaguchi H; Mafune K; Tange T; Tatematsu M; Kaminishi M Int J Cancer; 2003 May; 105(1):136-43. PubMed ID: 12672044 [TBL] [Abstract][Full Text] [Related]
24. Quantitative analysis of estrogen receptor-alpha and -beta messenger RNA expression in breast carcinoma by real-time polymerase chain reaction. Iwao K; Miyoshi Y; Egawa C; Ikeda N; Tsukamoto F; Noguchi S Cancer; 2000 Oct; 89(8):1732-8. PubMed ID: 11042568 [TBL] [Abstract][Full Text] [Related]
25. Correlation of DNA flow cytometry and hormone receptors with axillary lymph node status in patients with carcinoma of the breast. Friedman NS; Freedman MD Md Med J; 1994 Nov; 43(11):963-5. PubMed ID: 7808198 [TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of intraperitoneal cancer cells in gastric carcinoma: detection of cytokeratin 20 mRNA in peritoneal washes, in addition to detection of carcinoembryonic antigen. Kodera Y; Nakanishi H; Ito S; Yamamura Y; Fujiwara M; Koike M; Hibi K; Ito K; Tatematsu M; Nakao A Gastric Cancer; 2005; 8(3):142-8. PubMed ID: 16086116 [TBL] [Abstract][Full Text] [Related]
27. Prediction of axillary lymph node status of breast cancer patients by tumorbiological factors of the primary tumor. Fehm T; Maul H; Gebauer S; Scharf A; Baier P; Sohn C; Jäger W; Gebauer G Strahlenther Onkol; 2005 Sep; 181(9):580-6. PubMed ID: 16170485 [TBL] [Abstract][Full Text] [Related]
28. One-Step Nucleic Acid Amplification Assay for Detection of Axillary Lymph Node Metastases in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy. Takamoto K; Shimazu K; Naoi Y; Shimomura A; Shimoda M; Kagara N; Kim SJ; Tamaki Y; Noguchi S Ann Surg Oncol; 2016 Jan; 23(1):78-86. PubMed ID: 26152274 [TBL] [Abstract][Full Text] [Related]
29. Detection of hepatocyte growth factor/scatter factor receptor (c-Met) and MUC1 from the axillary fluid drainage in patients after breast cancer surgery. Greenberg R; Barnea Y; Schneebaum S; Kashtan H; Kaplan O; Skornik Y Isr Med Assoc J; 2003 Sep; 5(9):649-52. PubMed ID: 14509156 [TBL] [Abstract][Full Text] [Related]
30. [Detection of breast cancer micrometastases in lymph nodes by amplification of keratin 19 mRNA with reverse-transcriptase polymerase chain reaction]. Noguchi S; Aihara T; Motomura K; Inaji H; Koyama H Gan To Kagaku Ryoho; 1996 Mar; 23 Suppl 1():50-5. PubMed ID: 8702311 [TBL] [Abstract][Full Text] [Related]
31. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma. Barth A; Craig PH; Silverstein MJ Cancer; 1997 May; 79(10):1918-22. PubMed ID: 9149018 [TBL] [Abstract][Full Text] [Related]
32. Multimarker RT-PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patients. Nissan A; Jager D; Roystacher M; Prus D; Peretz T; Eisenberg I; Freund HR; Scanlan M; Ritter G; Old LJ; Mitrani-Rosenbaum S Br J Cancer; 2006 Mar; 94(5):681-5. PubMed ID: 16495929 [TBL] [Abstract][Full Text] [Related]
33. Breast-specific expression of MGB1/mammaglobin: an examination of 480 tumors from various organs and clinicopathological analysis of MGB1-positive breast cancers. Sasaki E; Tsunoda N; Hatanaka Y; Mori N; Iwata H; Yatabe Y Mod Pathol; 2007 Feb; 20(2):208-14. PubMed ID: 17192791 [TBL] [Abstract][Full Text] [Related]
34. Detection of circulating tumor cells in early-stage breast cancer metastasis to axillary lymph nodes. Nakagawa T; Martinez SR; Goto Y; Koyanagi K; Kitago M; Shingai T; Elashoff DA; Ye X; Singer FR; Giuliano AE; Hoon DS Clin Cancer Res; 2007 Jul; 13(14):4105-10. PubMed ID: 17634536 [TBL] [Abstract][Full Text] [Related]
35. Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study. Gillanders WE; Mikhitarian K; Hebert R; Mauldin PD; Palesch Y; Walters C; Urist MM; Mann GB; Doherty G; Herrmann VM; Hill AD; Eremin O; El-Sheemy M; Orr RK; Valle AA; Henderson MA; Dewitty RL; Sugg SL; Frykberg E; Yeh K; Bell RM; Metcalf JS; Elliott BM; Brothers T; Robison J; Mitas M; Cole DJ Ann Surg; 2004 Jun; 239(6):828-37; discussion 837-40. PubMed ID: 15166962 [TBL] [Abstract][Full Text] [Related]
36. Quantification of colorectal cancer micrometastases in lymph nodes by nested and real-time reverse transcriptase-PCR analysis for carcinoembryonic antigen. Ho SB; Hyslop A; Albrecht R; Jacobson A; Spencer M; Rothenberger DA; Niehans GA; D'Cunha J; Kratzke RA Clin Cancer Res; 2004 Sep; 10(17):5777-84. PubMed ID: 15355906 [TBL] [Abstract][Full Text] [Related]
37. Mammaglobin, a potential marker of breast cancer nodal metastasis. Leygue E; Snell L; Dotzlaw H; Hole K; Troup S; Hiller-Hitchcock T; Murphy LC; Watson PH J Pathol; 1999 Sep; 189(1):28-33. PubMed ID: 10451484 [TBL] [Abstract][Full Text] [Related]
38. Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. Gargano G; Agnese V; Calò V; Corsale S; Augello C; Bruno L; La Paglia L; Gullo A; Ottini L; Russo A; Fulfaro F; Rinaldi G; Crosta A; Cicero G; Majorana O; Palmeri L; Cipolla C; Agrusa A; Gulotta G; Morello V; Di Fede G; Adamo V; Colucci G; Tomasino RM; Valerio MR; Bazan V; Russo A; Ann Oncol; 2006 Jun; 17 Suppl 7():vii41-5. PubMed ID: 16760290 [TBL] [Abstract][Full Text] [Related]
39. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR. Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345 [TBL] [Abstract][Full Text] [Related]
40. Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA. Yie SM; Luo B; Ye NY; Xie K; Ye SR Clin Exp Metastasis; 2006; 23(5-6):279-89. PubMed ID: 17086357 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]